Schedule 13G ownership disclosure

SATSUMA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80405P107

Event date: 2019-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,405,295
Percent of class
13.5800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000456
Form type
SC 13G
Filer
Satsuma Pharmaceuticals, Inc.
CIK
CIK 1692830
Filed
Oct 10, 2019
Reporting period
Sep 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub